🇺🇸 FDA
Patent

US 10258635

Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseases

granted A61KA61K31/593A61K9/0019

Quick answer

US patent 10258635 (Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseases) held by Aphios Corporation expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aphios Corporation
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/593, A61K9/0019, A61K9/127, A61K9/4858